Rationale and design of the national emphysema treatment trial (NETT): A prospective randomized trial of lung volume reduction surgery (Q62085996)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469970%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

title

Rationale and design of the National Emphysema Treatment Trial (NETT): A prospective randomized trial of lung volume reduction surgery (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469970%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference

language of work or name

English

0 references

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469970%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Thoracic and Cardiovascular Surgery

12 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469970%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469970%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469970%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

page(s)

518-528

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469970%20AND%20SRC:MED&resulttype=core&format=json

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

12 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Quality of life changes in COPD patients treated with salmeterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Guidelines for the approach to the patient with severe hereditary alpha-1-antitrypsin deficiency. American Thoracic Society

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Thoracoscopic carbon dioxide laser treatment of bullous emphysema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

A randomized, prospective trial of stapled lung reduction versus laser bullectomy for diffuse emphysema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Should lung volume reduction for emphysema be unilateral or bilateral?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Bilateral volume reduction surgery for diffuse pulmonary emphysema by video-assisted thoracoscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Lung volume reduction surgery: lessons learned

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Lung volume reduction surgery. Case selection, operative technique, and clinical results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Extended indications for lung volume reduction surgery in advanced emphysema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Functional improvement after volume reduction: sternotomy versus videoendoscopic approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Psychophysical bases of perceived exertion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Timed walking tests of exercise capacity in chronic cardiopulmonary illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Multifactorial index of cardiac risk in noncardiac surgical procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

Sample size calculation for complex clinical trials with survival endpoints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970191-1

10.1016/S0022-5223(99)70191-1

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10469970%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference